Genesco Inc. Reports Strong Fiscal 2027 Q1 Results: Raises EPS Outlook, Announces \$40-\$50 Million Cost Savings Program
Highlights
- Q1 results exceeded expectations on both sales and profitability metrics.
- Seventh consecutive quarter of positive total comparable sales growth.
- Strong performance at Journeys (+5% comparable sales) and Johnston & Murphy (+7% comparable sales).
- Announced a new \$40 to \$50 million cost savings program through Fiscal 2029.
- Raised full-year adjusted EPS outlook to \$2.00–\$2.40 (previously \$1.90–\$2.30).
- Company expects \$23–\$25 million in tariff refunds, not yet included in financials or guidance.
Financial Performance: Q1 Fiscal 2027
- Net Sales: \$487 million, up 3% year-over-year (YoY).
- Comparable Sales: Up 2% overall, driven by 3% same-store sales growth; e-commerce flat.
- Gross Margin: Improved by 30 basis points to 47.0% of sales, up from 46.7% YoY, attributable to improved shipping/warehouse efficiency and reduced promotional activity.
- Selling & Administrative Expenses: Improved to 52.2% of sales (vs. 52.5% last year); adjusted SGA at 51.9% of sales, reflecting cost savings and lower salaries/occupancy/freight, partially offset by higher incentive compensation and marketing.
- Operating Loss: GAAP operating loss of \$15.4 million (-3.2% of sales), compared to a \$28.1 million loss (-5.9%) last year. Adjusted operating loss was \$23.9 million (-4.9%) vs. \$27.9 million (-5.9%).
- Net Loss: GAAP net loss of \$14.8 million (-3.0% of sales) or \$1.42 per share, improved from \$21.2 million (-4.5%) or \$2.02 per share last year. Adjusted non-GAAP net loss was \$22.7 million, or \$2.18 per share.
- Tax Rate: Effective tax rate dropped sharply to 6.8% (adjusted 6.9%), from 28.5% (adjusted 26.7%) in the prior year, largely due to a valuation allowance and tax law changes under the One Big Beautiful Bill Act (“OBBBA”).
- Cash: \$27.1 million as of May 2, 2026, up from \$21.7 million YoY.
- Debt: \$45.3 million, significantly down from \$121.0 million last year.
- Inventory: Up 6% YoY, driven by increased Journeys inventory, partially offset by reduced inventory at Genesco Brands.
Segment Results
- Journeys Group: Sales rose 5% to \$285.3 million (58.6% of total sales); operating loss improved to \$11.6 million (-4.0% of sales).
- Schuh Group: Sales declined 5% to \$90.7 million (18.6% of sales); operating loss widened to \$7.0 million (-7.7%). On constant currency, sales down 9% YoY due to reduced promotional activity in favor of full-price sales.
- Johnston & Murphy Group: Sales up 6% to \$81.3 million (16.7% of sales); operating income improved to \$1.5 million (1.9% of sales).
- Genesco Brands Group: Sales up 4% to \$29.7 million (6.1% of sales); operating income at \$1.2 million (3.9%).
Operational Updates
- Cost Savings Program: Aims to structurally reduce costs by \$40–\$50 million through Fiscal 2029, leveraging IT transformation, automation, and AI to drive efficiency and margin expansion.
- CapEx & Store Activity: \$15 million in capital expenditures focused on retail stores; 2 new stores opened, 30 closed. Total store count down 4% YoY to 1,208, with a 4% reduction in square footage.
- Share Repurchases: No shares repurchased in Q1. \$29.8 million remains on authorization (as of June 2023). 604,531 shares repurchased in Fiscal 2026.
Guidance and Outlook for Fiscal 2027
- Adjusted EPS Guidance: Raised to \$2.00–\$2.40 (previously \$1.90–\$2.30); midpoint (\$2.20) seen as most likely outcome.
- Comparable Sales: Company expects another year of positive growth, with guidance for 1–2% positive comparable sales.
- Total Sales: Expected to be down 1% to flat YoY, reflecting impacts of store closures and license exits.
- Gross Margin: Expected to improve, especially at Schuh, as the company shifts toward full-price, full-margin sales.
- Tax Rate: Full-year guidance assumes 30%, but Q2 and Q3 will be in the range of 7–8% due to the valuation allowance.
- Tariff Refunds: \$23–\$25 million in expected refunds (pending application approval) not included in guidance/fiscal results. This could be a significant windfall for future quarters.
Key Shareholder/Price Sensitive Considerations
- Earnings Upside: Raised EPS guidance reflects improving profitability, which is positive for share valuation.
- Cost Savings Program: Long-term structural cost reductions of \$40–\$50 million could support higher margins and earnings multiple.
- Tariff Refunds: Potential \$23–\$25 million in refunds not yet recognized in results or guidance could provide future upside.
- Store Closures: Ongoing rationalization of the store fleet continues, supporting cost optimization, but may cap top-line growth.
- Low Effective Tax Rate: Temporary benefit from OBBBA and valuation allowance, but expected to normalize to 30% in the long run.
- Share Repurchases: Remaining authorization provides flexibility for capital return, supporting share price.
Risks and Forward-Looking Statements
Genesco highlighted several risks in its outlook, including consumer demand shifts, supply chain disruptions, impacts from tariffs and refunds, store traffic patterns, labor costs, inflation, competition, and the effectiveness of its cost savings and digital initiatives.
Investors should note that the guidance excludes the impact of any future share repurchases and the expected tariff refunds, and that the company’s effective tax rate will be lower in the upcoming quarters due to tax law changes.
About Genesco Inc.
Genesco Inc. (NYSE: GCO) is a specialty retailer with a portfolio including Journeys, Schuh, Johnston & Murphy, and Genesco Brands (Wrangler, Dockers, Starter, and others). As of May 2, 2026, Genesco operated over 1,200 stores, with a significant e-commerce presence and omnichannel capabilities.
Conference Call and Further Information
The company held a conference call on May 29, 2026, and posted detailed financial commentary and presentations on its investor relations website.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Forward-looking statements are subject to risks and uncertainties. Investors should consult the company’s SEC filings and conduct their own analysis before making investment decisions.
